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EditorialDiversity-Oriented Organic Synthesis
and Proteomics: New Frontiers
for Chemistry & Biology
This strikingly new-look issue of Chemistry & Biology—the pleasure to welcome back Rebecca Ward, the founding
managing editor of Chemistry & Biology and currently Di-first to be published under the auspices of Cell Press—
gives new meaning to the term “combinatorial chemistry.” rector of Research Affairs at the Harvard Institute of Chem-
istry and Cell Biology, as the journal’s Consulting Editor.For those keeping score, this marks the journal’s fourth
home in the past five years, as operations have flipped From the editorial perspective, Chemistry & Biology will
continue to present exciting cross-disciplinary researchfrom San Francisco to London and then, after the acquisi-
tion of Current Biology Ltd. by Elsevier, to Amsterdam. and will renew its commitment to publishing accessible
and informative front matter, including previews, CrosstalkWhile these earlier moves were largely beyond our control,
the latest—and one hopes final—move to the Cambridge, essays, and occasional features. Following last year’s
completion of the draft human genome sequence, thereMassachusetts, home of Cell Press, is of our own choos-
ing, and it marks what we hope is the beginning of a fruitful has never been greater interest in the interface between
chemistry, biology, and other disciplines. For example, thelong-term relationship.
The opportunity to join Cell Press presented itself mid- Howard Hughes Medical Institute recently purchased near
Washington D.C.’s Dulles Airport some 300 acres of land,way through 2001 and makes great sense for Chemistry &
Biology and our loyal community of readers and contribu- known as Janelia Farm, where it will open a modern re-
search facility housing more than 20 research groupstors. Cell Press is the publisher of Cell and seven other
outstanding journals (including our original sister journals, drawn from the fields of chemistry, physics, engineering,
bioinformatics, and molecular biology. Similar initiativesCurrent Biology and Structure) spanning the realm of bio-
medical research. The editorial principles evident at Cell are sprouting at universities across the United States and
elsewhere. We feel that Chemistry & Biology is ideallyPress are in keeping with those that guided the launch of
Chemistry & Biology back in 1994: expert editorial assess- placed to capture this excitement and become essential
reading for a growing number of researchers who arement, efficient manuscript handling, and prompt publica-
tion. The visibility afforded by Cell Press both in print and helping to blur traditional boundary lines.
Having said this, there are two areas that we are particu-online will help us to find many new potential readers and
contributors within the biology community. We are also larly keen to see flourish this year. The first is diversity-
oriented synthesis (DOS), which aims to produce structur-excited to reach out to more traditional chemists who are
just starting to appreciate the new opportunities afforded ally complex and diverse small molecules efficiently. When
coupled with small-molecule screening (both phenotypicby the interface of chemistry and biology.
So what changes lie in store for Chemistry & Biology in and proteomic) and informatics, DOS promises to facilitate
a chemical approach to exploring biology in a systematic2002 and beyond? The most obvious is the journal’s new
appearance, one that will be familiar to readers of other way. As synthetic chemists trained in target-oriented syn-
thesis (TOS) begin to explore the challenges of DOS, theyCell Press titles. Allowing greater flexibility for cover de-
sign, we have retired the sky-blue trim that adorned every also often experience the growing pains of journals cen-
tered about traditional aspects of synthesis. Chemistry &cover until now. The layout of the research papers is now
in the sans serif Cell Press format. Authors should note Biology has a clear appreciation of the significance of
advances in (1) the planning of DOS syntheses (pathwaysome minor changes to the style of research papers; while
we are retaining the Vancouver (numerical) citation method development), (2) the realization of library syntheses in
useful formats, and (3) the use of DOS-derived small mole-and the “Significance” section, articles will no longer have
numbered sections in the text, and the new abstract style cules in biological experiments. We aim to be flexible and
inviting in our interactions with synthetic chemists whoconsists of a single, seamless paragraph. We are also
keen to consider more succinct papers that might occupy encounter the many challenges of a new field. We aim to
learn from our contributors what constitutes an importantonly a few printed pages, “Communications” in the lan-
guage of American Chemical Society journals, provided advance in this field, rather than to dictate in advance a
rigid set of rules.they report results of unusual significance for the field.
Our major priority for 2002 is to improve the handling and The second area where Chemistry & Biology is well
placed to present cutting-edge research is—not unpre-speed of publication of all research manuscripts, former
hallmarks of Chemistry & Biology. We are delighted to dictably—proteomics. There has been an explosion of in-
terest in both academia and industry in new techniqueswelcome Dr. Victoria Mountain as Chemistry & Biology’s
new Assistant Editor; Victoria will provide authors with and procedures for studying protein chemistry and func-
tion, including structural determination, localization, pro-expert scientific advice at Cell Press and oversee the peer
review system in conjunction with our Associate Editors. tein-protein interactions, and so on. This field is intrinsically
dependent on advances in both chemistry and biology,(If authors should experience any difficulties or delays
during this transition period, we will do everything possible and we strongly encourage authors in this field to consider
Chemistry & Biology in disseminating their results. This isto set matters straight.) We are delighted that Ronald
Breaker and Michael Famulok have joined the team of a wide-open field that means different things to different
people. We again take a learning, open view of the field andAssociate Editors, but we are sorry to lose the services
of Patrick Baeuerle, who is stepping down after having anticipate contributions ranging from analytic chemistry to
array technology to high-throughput methods for vectorserved Chemistry & Biology since its inception. A replace-
ment for Patrick will be named shortly. Finally, it is a great and recombinant protein production. We envision applica-
Chemistry & Biology
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tions ranging from analyses of protein functions to protein
profiling to comparisons of whole proteomes.
This promises to be an exciting new chapter for Chemis-
try & Biology and our field. It only remains for us to thank
our former publisher, Bas van der Hoek, in-house editor
Gepke Uiterdijk, and colleagues in Amsterdam for their
efforts during 2001 and assistance in facilitating the move
to Cell Press. We are indebted to Lynne Herndon, CEO
of Cell Press, for her belief in Chemistry & Biology, our
community, and above all, combinatorial chemistry.
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